Impact of COVID-19, lockdowns and vaccination on immune responses in a HIV cohort in the Netherlands

Front Immunol. 2024 Dec 18:15:1459593. doi: 10.3389/fimmu.2024.1459593. eCollection 2024.

Abstract

Introduction: During the COVID-19 pandemic, major events with immune-modulating effects at population-level included COVID-19 infection, lockdowns, and mass vaccinations campaigns. As immune responses influence many immune-mediated diseases, population scale immunological changes may have broad consequences.

Methods: We investigated the impact of lockdowns, COVID-19 infection and vaccinations on immune responses in the 2000HIV study including 1895 asymptomatic virally-suppressed people living with HIV recruited between October 2019 and October 2021. Their inflammatory profile was assessed by targeted plasma proteomics, immune responsiveness by cytokine production capacity of circulating immune cells, and epigenetic profile by genome-wide DNA methylation of immune cells.

Results: Past mild COVID-19 infection had limited long-term immune effects. In contrast, COVID-19 vaccines and especially lockdowns significantly altered both the epigenetic profile in immune cells at DNA methylation level and immune responses. Lockdowns resulted in a strong overall exaggerated immune responsiveness, while COVID-19 vaccines moderately dampened immune responses. Lockdown-associated immune responsiveness alterations were confirmed in 30 healthy volunteers from the 200FG cohort that, like the 2000HIV study, is part of the Human Functional Genomics Project.

Discussion: Our data suggest that lockdowns have unforeseen immunological effects. Furthermore, COVID-19 vaccines have immunological effects beyond anti-SARS-CoV-2 activity, and studies of their impact on non-COVID-19 immune-mediated pathology are warranted.

Keywords: COVID-19; hygiene hypothesis; inflammation; lockdown; vaccination.

MeSH terms

  • Adult
  • COVID-19 Vaccines* / immunology
  • COVID-19* / immunology
  • COVID-19* / prevention & control
  • Cohort Studies
  • Cytokines
  • DNA Methylation
  • Epigenesis, Genetic
  • Female
  • HIV Infections* / immunology
  • Humans
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • SARS-CoV-2* / immunology
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Cytokines

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The 2000HIV was funded by ViiV Healthcare (A18-1052). ViiV healthcare grant awarded to AV, MN, and LJ. LJ is supported by a Competitiveness Operational Program Grant of the Romanian Ministry of European Funds (HINT, ID P_37_762; MySMIS 103587). MGN is supported by an ERC Advanced Grant (#833247) and a Spinoza Grant of the Netherlands Organization for Scientific Research. C-JX was supported by the Helmholtz Initiative and Networking Fund (1800167) and Deutsche Forschungsgemeinschaft (DFG) (497673685). YL was supported by an ERC Starting Grant (948207) and the Radboud University Medical Centre Hypatia Grant (2018) for Scientific Research.